Efficacy and tolerability of folfirinox in treatment of advanced pancreatic cancer patients /
Haider Yousif Hameed Shukur
Efficacy and tolerability of folfirinox in treatment of advanced pancreatic cancer patients / فعالية و قابلية تحمل علاج فولفيرينوكس فى علاج حالات أورام البنكرياس المتقدم و المنتشر Haider Yousif Hameed Shukur ; Supervised Ehsan Gamal Eldin Elghonemy , Hanan Selim Mosalem , Amr Yehia Sakr - Cairo : Haider Yousif Hameed Shukur , 2013 - 149 P. : charts ; 25cm
Thesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Oncology-Clinical
In compares of FOLFIRINOX to Gemciabine group according to treatment line, we find that the ORR to FOLFIRINOX was 45% versus 10% in Gemcitabine arm also overall survival was 11 months versus 7 months although the toxicity of this protocol was greater than Gemcitabine, but all was manageable and tolerable
FOLFIRINOX Gemcitabine vs
Efficacy and tolerability of folfirinox in treatment of advanced pancreatic cancer patients / فعالية و قابلية تحمل علاج فولفيرينوكس فى علاج حالات أورام البنكرياس المتقدم و المنتشر Haider Yousif Hameed Shukur ; Supervised Ehsan Gamal Eldin Elghonemy , Hanan Selim Mosalem , Amr Yehia Sakr - Cairo : Haider Yousif Hameed Shukur , 2013 - 149 P. : charts ; 25cm
Thesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Oncology-Clinical
In compares of FOLFIRINOX to Gemciabine group according to treatment line, we find that the ORR to FOLFIRINOX was 45% versus 10% in Gemcitabine arm also overall survival was 11 months versus 7 months although the toxicity of this protocol was greater than Gemcitabine, but all was manageable and tolerable
FOLFIRINOX Gemcitabine vs